Document is current
Any future updates will be listed below
-
Authors
Lindell, Emma https://orcid.org/0009-0001-2785-946X
Guo, Jing https://orcid.org/0000-0002-6399-3877
Zhao, Miao https://orcid.org/0000-0002-4895-1177
Rameika, Natallia
Lu, Xi
Wacker, Tabea
Zhong, Lei
Bergström, Tobias
Svanberg, Sara
Chowdhury, Azazul I.
Bergsten, Peter
Chen, Xingqi https://orcid.org/0000-0002-5657-2839
Bexell, Daniel
Swartling, Fredrik J. https://orcid.org/0000-0002-8460-4367
Sjöblom, Tobias https://orcid.org/0000-0001-6668-4140
Zhang, Xiaonan https://orcid.org/0000-0003-4359-9079
-
Funding
Funding for this research was provided by:
Barncancerfonden (TJ2021-0111)
Barncancerfonden (PR2022-0071)
Jeanssons Stiftelser (No.)
Stiftelsen för Strategisk Forskning (CMP22-0014)
- License Information
-
More Information
Article History
Received: 23 September 2024
Revised: 23 May 2025
Accepted: 9 July 2025
First Online: 23 July 2025
Competing interests
: The authors declare no competing interests.
: Neuroblastoma PDX-derived cells LU-NB-1 and LU-NB-2, obtained from Professor Daniel Bexell (ethic approve ref. no. 2016/1055, 2018/155). All methods were performed in accordance with the relevant guidelines and regulations. This study did not include any animal work. This study did not include human research participants. No remaining ethical issues warrant consideration.
